UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000047006 |
|---|---|
| Receipt number | R000053635 |
| Scientific Title | The investigation of the relationship between left atrial appendage and clinical data |
| Date of disclosure of the study information | 2022/03/01 |
| Last modified on | 2024/01/26 16:29:14 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The investigation of the relationship between left atrial appendage and clinical data
Acronym
Left atrial appendage analysis
Scientific Title
The investigation of the relationship between left atrial appendage and clinical data
Scientific Title:Acronym
Analysis of left atrial appendage by single cell RNA sequencing
Region
| Japan |
Condition
Condition
Atrial fibrillation
Classification by specialty
| Medicine in general |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify the difference of characterization between left atrial appendage with thrombosis and without thrombosis by single-cell RNA sequencing
Basic objectives2
Others
Basic objectives -Others
Elucidation of the mechanism of the thrombus formation of left atrial appendage
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Cluster analysis of single-cell RNA sequencing and cluster analysis of gene expression variation in each cluster on both left atrial appendage with thrombosis and without thrombosis
Key secondary outcomes
Relationship between left atrial appendage collected by left atrial appendage resection and various left atrial appendage data
1. Bulk RNA sequencing
2. micro RNA sequencing
3. Histological evaluation
4. single cell RNA sequencing of blood sample
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
(1) Patients who underwent left atrial appendage resection
(2) Patients 20 years of age or older at the time of left atrial appendage resection
(3) Patients for whom written consent has been obtained by the individual
Key exclusion criteria
(1) Patients taking steroids, autoimmune diseases, undergoing treatment for cancer, or suffering from hepatitis B and C viruses
(2) Other patients who are deemed inappropriate by the physician in charge of the study
Target sample size
32
Research contact person
Name of lead principal investigator
| 1st name | Koji |
| Middle name | |
| Last name | Fukuzawa |
Organization
Kobe University Hospital
Division name
The division of Cardiovascular medicine
Zip code
650-0017
Address
7-5-2, Kusunoki-cho, Kobe, Japan
TEL
078-382-5846
kfuku@med.kobe-u.ac.jp
Public contact
Name of contact person
| 1st name | Koji |
| Middle name | |
| Last name | Fukuzawa |
Organization
Kobe University Hospital
Division name
The division of Cardiovascular medicine
Zip code
650-0017
Address
7-5-2, Kusunoki-cho, Kobe, Japan
TEL
078-382-5846
Homepage URL
kfuku@med.kobe-u.ac.jp
Sponsor or person
Institute
Kobe University Hospital
Institute
Department
Personal name
Funding Source
Organization
Kobe University Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kobe University Hospital
Address
7-5-2, Kusunoki-cho, Kobe, Japan
Tel
078-382-5111
chiken@med.kobe-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 03 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2021 | Year | 07 | Month | 01 | Day |
Date of IRB
| 2021 | Year | 08 | Month | 20 | Day |
Anticipated trial start date
| 2021 | Year | 08 | Month | 20 | Day |
Last follow-up date
| 2025 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
| 2027 | Year | 12 | Month | 31 | Day |
Date trial data considered complete
Date analysis concluded
Other
Other related information
Prospective observational study
Management information
Registered date
| 2022 | Year | 02 | Month | 25 | Day |
Last modified on
| 2024 | Year | 01 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053635
